This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Libramen Naturals Inc.. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Renata Ciccarelli: Innovator in G-Protein Coupled Receptor Research
Introduction
Renata Ciccarelli is a prominent inventor based in Chieti, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of cell lines that express G-Protein Coupled Receptors (GPCRs). With a total of 2 patents, her work is paving the way for advancements in understanding guanosine analogues and their potential applications.
Latest Patents
Ciccarelli's latest patents focus on transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors. The first patent discloses techniques for transforming Drosophila Schneider 2 cells and human astrocytoma 1321N1 cells to express GPCR22. These transformed cell lines are instrumental in identifying guanosine analogues and functional equivalents. The second patent similarly details the methods of use for these cell lines in identifying binding compounds related to GPCR22.
Career Highlights
Renata Ciccarelli is currently associated with Libramen Naturals Inc., where she continues her innovative research. Her work has garnered attention in the scientific community for its potential applications in drug discovery and therapeutic development.
Collaborations
Ciccarelli collaborates with notable colleagues, including Michel P Rathbone and Shucui Jiang. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Renata Ciccarelli's contributions to the field of biotechnology through her patents and research are noteworthy. Her innovative work on G-Protein Coupled Receptors is set to have a lasting impact on drug discovery and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile